DELPHARM
keyboard_backspaceBack to Home
Contact
Delpharm DELRIV Port de Boulogne-Billancourt Face au 9 quai du 4 septembre
92100 Boulogne-Billancourt
France
Business Development Manager
About us
Delpharm is a worldwide leader in contract manufacturing and development of medicines.
For over 35 years, Delpharm has built up its position by acquiring manufacturing plants over the years, in particular from big pharmaceutical companies. Delpharm’s plants based in Canada, France, Italy, the Netherlands and Poland produce more than a billion boxes of medicines a year.
The company employs more than 6,500 people and has achieved in 2023 a revenue of €1.1 billion.
Committted to optimising and expanding our industrial facilities, Delpharm invests between 80 million euros each year in production facilities.
Business offer
As multi-specialists, Delpharm is able to supply the majority of pharmaceutical forms available on the market, such as tablets and capsules, bottles and injectable ampoules, prefilled syringes, freeze-drying, suspensions, solutions, ointments and soft gel capsules.
Delpharm also offers full development services for a wide range of pharmaceutical forms, chemical entities and innovative combinations, including the production of phase 1 to 3 clinical batches for solid, semi-solid, liquid and injectable forms.
Activities
- Service
- Cardiology
- Genetic Diseases
- Oncology
- Nervous Central System
- Hematology
- Infectiology
- Immunology
- Ophthalmology
- Inflammation
- CMC
- GLP compliance
- for preclinical NCS (non-clinical safety) studies
- viral safety testing
- GMP compliance
- Formulation
- Formulation
- Adjuvants
- Stabilization
- Excipients
- Vaccines Combination
- Lyophilization
- Shipment Monitoring
- Vaccine delivery/Administration routes
- Route of Administration
- Intramuscular route
- intradermal route
- Nasal route
- Mucosal routes
- Other devices: specify
- Regulatory safety
- Specificity
- Human sequence homologies
- Regulatory safety tests
- Viral safety
- Hypersensitivity
- Immunotoxicology
- Clinical trials
- Phase I
- Phase II (human challenge trials)
- Phase III (large population pending pathogen prevalence)
- Immune monitoring
- Data management
- Fill & finish
- Lyophilization
- Prefilled syringe
- Vaccine shipment and distribution
- Storage matter
- Labelling
- Packaging for shipping
- Instruction Label
- Digitalization of bar code
- Cold chain logistics
- Quality control & analytical process monitoring
- Stability Assessment
- Biosafety & Bioanalysis
- Toxicology
- Immune response characterization
- Viral safety
- Bioproduction analytical monitoring
- Key and critical process parameters (KCP, CPP)
- Identification
- Monitoring
- Batch release test
- Chemical, physical, biological testing
- Potency assay
- Challenge animal models
- Impurities detection
- Quality control test support
- Regulatory Filing
- Regulatory Filing
- New Drug Application (IND)
- Investigational Medicinal Product (IMPT) for clinical investigations (EMA)
- Common Technical document (CTD) section 3 (CMC) 4 (NCS) and 5 (Clinics) for submission
